{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:17:38Z","timestamp":1795033058268,"version":"4.10.2"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.3201\/eid3111.250584","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:18:27Z","timestamp":1767896307000},"page":"2167-2171","source":"Crossref","is-referenced-by-count":0,"title":["<i>Borrelia afzelii<\/i>\n                    Hepatitis in Patient Treated with Venetoclax and Obinutuzumab, Switzerland"],"prefix":"10.3201","volume":"31","author":[{"given":"Gioele","family":"Capoferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Battegay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Hamelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten D.","family":"Mertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Weisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3111.250584-202601081315-R1","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis.","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"key-10.3201\/eid3111.250584-202601081315-R2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis.","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"key-10.3201\/eid3111.250584-202601081315-R3","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3201\/eid2708.204763","article-title":"Comparison of Lyme Disease in the United States and Europe.","volume":"27","author":"Marques","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3111.250584-202601081315-R4","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1086\/339871","article-title":"Gastrointestinal and hepatic manifestations of tickborne diseases in the United States.","volume":"34","author":"Zaidi","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3111.250584-202601081315-R5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.idc.2022.03.005","article-title":"Early Lyme disease (erythema migrans) and its mimics (Southern tick-associated rash illness and tick-associated rash illness).","volume":"36","author":"Strle","year":"2022","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.3201\/eid3111.250584-202601081315-R6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bpg.2013.06.011","article-title":"Hepatic changes in systemic infection.","volume":"27","author":"Srivastava","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key-10.3201\/eid3111.250584-202601081315-R7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(87)93009-1","article-title":"Granulomatous hepatitis associated with Lyme disease.","volume":"2","author":"Chavanet","year":"1987","journal-title":"Lancet"},{"key":"key-10.3201\/eid3111.250584-202601081315-R8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.7326\/0003-4819-108-5-707","article-title":"Hepatitis due to recurrent Lyme disease.","volume":"108","author":"Goellner","year":"1988","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid3111.250584-202601081315-R9","first-page":"193","article-title":"[Hepatic disorders related to Lyme disease. Study of two cases and a review of the literature]","volume":"25","author":"Dadamessi","year":"2001","journal-title":"Gastroenterol Clin Biol"},{"key":"key-10.3201\/eid3111.250584-202601081315-R10","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s10620-006-9405-9","article-title":"Necrotizing granulomatous hepatitis as an unusual manifestation of Lyme disease.","volume":"52","author":"Zanchi","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key-10.3201\/eid3111.250584-202601081315-R11","doi-asserted-by":"crossref","unstructured":"Middelveen MJ, McClain SA, Bandoski C, Israel JR, Burke J, MacDonald AB,  Granulomatous hepatitis associated with chronic\n                      Borrelia burgdorferi\n                      infection: a case report. Research. 2014;1:875. 10.13070\/rs.en.1.875","DOI":"10.13070\/rs.en.1.875"},{"key":"key-10.3201\/eid3111.250584-202601081315-R12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12941-022-00506-6","article-title":"An unexpected case of Borrelia garinii liver infection.","volume":"21","author":"Duffau","year":"2022","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"key-10.3201\/eid3111.250584-202601081315-R13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.1855","article-title":"An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells.","volume":"11","author":"Lee","year":"2010","journal-title":"Nat Immunol"},{"key":"key-10.3201\/eid3111.250584-202601081315-R14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1749-6632.1988.tb31839.x","article-title":"Clinical pathologic correlations of Lyme disease by stage.","volume":"539","author":"Duray","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.3201\/eid3111.250584-202601081315-R15","doi-asserted-by":"crossref","unstructured":"Maraspin V, Bogovi\u010d P, Rojko T, Ru\u017ei\u0107-Sablji\u0107 E, Strle F. Erythema migrans: course and outcome in patients treated with rituximab. Open Forum Infect Dis. 2019;6:ofz292. 10.1093\/ofid\/ofz292","DOI":"10.1093\/ofid\/ofz292"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/31\/11\/25-0584_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:18:22Z","timestamp":1795029502000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/31\/11\/25-0584_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3111.250584","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}